Cullinan Therapeutics (CGEM) Interest & Investment Income: 2021-2023
Historic Interest & Investment Income for Cullinan Therapeutics (CGEM) over the last 3 years, with Dec 2023 value amounting to $5.9 million.
- Cullinan Therapeutics' Interest & Investment Income rose 75.89% to $5.9 million in Q4 2023 from the same period last year, while for Dec 2023 it was $21.6 million, marking a year-over-year increase of 227.14%. This contributed to the annual value of $29.7 million for FY2024, which is 37.14% up from last year.
- Cullinan Therapeutics' Interest & Investment Income amounted to $5.9 million in Q4 2023, which was up 0.63% from $5.9 million recorded in Q3 2023.
- In the past 5 years, Cullinan Therapeutics' Interest & Investment Income ranged from a high of $5.9 million in Q4 2023 and a low of $49,000 during Q1 2021.
- Its 3-year average for Interest & Investment Income is $2.4 million, with a median of $1.5 million in 2022.
- Data for Cullinan Therapeutics' Interest & Investment Income shows a peak YoY soared of 2,355.47% (in 2022) over the last 5 years.
- Over the past 3 years, Cullinan Therapeutics' Interest & Investment Income (Quarterly) stood at $137,000 in 2021, then skyrocketed by 2,355.47% to $3.4 million in 2022, then skyrocketed by 75.89% to $5.9 million in 2023.
- Its Interest & Investment Income stands at $5.9 million for Q4 2023, versus $5.9 million for Q3 2023 and $5.3 million for Q2 2023.